TOPOKINE THERAPEUTICS INC has a total of 82 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are BEIJING CENTURY BIOCOM PHARM, LEGACY HEALTHCARE LTD and KRUTMANN JEAN.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 23 | |
#2 | EPO (European Patent Office) | 8 | |
#3 | WIPO (World Intellectual Property Organization) | 7 | |
#4 | Canada | 5 | |
#5 | Republic of Korea | 5 | |
#6 | China | 4 | |
#7 | Japan | 4 | |
#8 | Australia | 3 | |
#9 | Hong Kong | 3 | |
#10 | Israel | 3 | |
#11 | Mexico | 3 | |
#12 | Singapore | 3 | |
#13 | Brazil | 2 | |
#14 | Hungary | 2 | |
#15 | South Africa | 2 | |
#16 | Chile | 1 | |
#17 | Costa Rica | 1 | |
#18 | New Zealand | 1 | |
#19 | Philippines | 1 | |
#20 | Slovenia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Kalayoglu Murat V | 70 |
#2 | Singer Michael S | 63 |
#3 | Murat V Kalayoglu | 8 |
#4 | Pasquale Louis R | 6 |
#5 | Grosskreutz Cynthia L | 6 |
#6 | Michael S Singer | 5 |
#7 | Kalayoglu Murat | 1 |
#8 | Singer Michael | 1 |
Publication | Filing date | Title |
---|---|---|
WO2015200425A1 | Topical dosage regimen | |
WO2015179282A1 | Topical compositions comprising a thiazolidinedione | |
US2016067263A1 | Methods and compositions for topical delivery of prostaglandins to subcutaneous fat | |
CN109966240A | The subcutaneously composition and method of fatty local delivery prostaglandin | |
WO2014138426A2 | Methods and compositions for reducing body fat and adipocytes | |
CN104936595A | Methods and compositions for locally increasing body fat | |
WO2013096429A2 | Methods and compositions for reducing body fat and adipocytes | |
EP3378480A1 | Methods and compositions for treating obesity | |
CA2880399A1 | Use of bimatoprost free acid administered to the skin to reduce adipose tissue |